- 0
- 0
- 约10.07万字
- 约 84页
- 2025-10-22 发布于湖南
- 举报
South
SouthKorea
OntheCuspofaCure
IsAsiaPacificReadyforthePrecisionEra?
VContents
Executivesummary 4
1.0Introduction 11
1.1Evolutionofmedicines 12
1.2Driversofgrowthintheprecisionera 14
1.3Definitions 16
1.4Reportdevelopmentapproach 21
2.0SouthKorea 23
2.1Introduction 24
2.2Benefitsofprecisiontherapies 25
2.3Barrierstoaccess 33
2.4Recommendations 37
3.0Appendix 41
References 49
L.E.K.Consulting|OntheCuspofaCure3
Executivesummary
Overthenextdecade,thenatureofdisease
treatmentsandthewaymedicaltherapiesare
deliveredtopatientswilldramaticallychangeasa
resultoftechnologicalbreakthroughsindiagnostics,bigdataandartificialintelligence(AI).Cutting-
edgescientificadvanceslikegenomicprofilingare
transformingourunderstandingofwhatcauses
diseaseandareenablingresearcherstopredict
treatmentsuitabilityandoutcomesmoreaccuratelyforpatients.
Cutting-edgescientificadvanceslike
genomicprofilingaretransformingour
understandingofwhatcausesdisease
andareenablingresearcherstopredict
treatmentsuitabilityandoutcomesmoreaccuratelyforpatients.
Asaresultoftheseadvances,weareenteringa
transformativeperiodinmedicinethePrecision
Era,wherethefundamentalwayinwhichpatientsaretreatedisbeingredefined.InthePrecisionEra,medicineswillmoveawayfrombeinggenerically
prescribedandadministered,smallmolecule
treatmentsaimedatalleviatingsymptoms,which
requireregularmedicationtomanagechronic
conditions.Instead,treatmentsarebecominghighlytailoredtoindividualpatientsandprovidepatientswiththepotentialforacurativesolution,specifictotheirdisease.Wecallthisnewwaveofinnovative
diseasetreatmentsprecisiontherapi
原创力文档

文档评论(0)